47 results
8-K
EX-99.1
BTTX
Better Therapeutics Inc
11 Mar 24
Regulation FD Disclosure
9:01am
efficient scalability Current approaches generally lack solid clinical validation and FDA oversight to give healthcare providers confidence to implement
424B3
BTTX
Better Therapeutics Inc
28 Dec 23
Prospectus supplement
9:23pm
to extensive government regulation and oversight both in the United States and abroad, and our failure to comply with applicable requirements could harm … and guidelines, including the imposition of additional regulatory oversight around clinical testing generally or with respect to our product candidates
8-K
EX-10.1
fz9q9ky u50thmk
13 Dec 23
Entry into a Material Definitive Agreement
5:06pm
8-K
EX-99.1
4w65e2on0zp2mk
12 Jul 23
Better Therapeutics Receives FDA Authorization for AspyreRxTM to Treat Adults with Type 2 Diabetes
12:00am
8-K
EX-10.1
6fo1sy
11 May 23
Entry into a Material Definitive Agreement
5:23pm
424B3
qyidsyc
15 Nov 22
Prospectus supplement
9:56pm